주메뉴 바로가기 본문 바로가기
ESG

ESG Overview

LigaChem Biosciences Paves the Way for a Greener Tomorrow
with a Commitment to ESG for Future Generations.

ESG Management System

Goals

A company that leads the development of new medicine for mankind through open innovation.

Mission

t creates a virtuous cycle for stakeholders, including customers and shareholders, through sustainable management, centering on environmental and social values.

Strategy

  • 01

    Research and development through sustainable innovation

  • 02

    Transparent management and sustainable growth

  • 03

    Cooperation and participation through strengthening social responsibility

ESG rating

LigaChemBio Sciences is evaluating the level of sustainability management through the evaluation of ESG evaluation agencies. We are reviewing this and conducting improvement activities.

Korea ESG Standards Institute (KCGS) Evaluation Rating

Evaluation Year Evaluating Organization Overall Rating Environment Social Governance
2023 Korea ESG Standards Institute B B+ A+ C
2022 Korea ESG Standards Institute B C B+ B
2021 Korea ESG Standards Institute B C B+ B+
2020 Korea ESG Standards Institute B+ B B B+
2019 Korea ESG Standards Institute B+ B B B+

Materiality assessment

Ligachem Biosciences analyzed business impact and social interest among various sustainability management issues. Through this, a double materiality assessment was conducted to intensively report on issues with high priority.

Considering ESG Management System international standards and global initiatives, legal and institutional policies, media analysis, and peer industry benchmarking analysis, a total of 6 critical issues were selected out of 46 issue pools.

We will focus on managing the issues derived.

Materiality Map

No. a matter of grave concern Reporting Location GRI connection
1 Recruitment and Retention Strategy p.20-21 GRI 401, 404
2 Establishment of Environmental Management System and Performance Management p.13-14 -
3 Health protection of employees p.22-23 GRI 403
4 Waste management p.17 GRI 306
5 Ethical management p.30 GRI 205, 206-1
6 Stakeholder communication p.33 -